Metastable HIV-1 Surface Protein Env Sensitizes Cell Membranes to Transformation and Poration by Dual-Acting Virucidal Entry Inhibitors

Biochemistry. 2020 Feb 18;59(6):818-828. doi: 10.1021/acs.biochem.9b01008. Epub 2020 Jan 28.

Abstract

Dual-acting virucidal entry inhibitors (DAVEIs) have previously been shown to cause irreversible inactivation of HIV-1 Env-presenting pseudovirus by lytic membrane transformation. This study examined whether this transformation could be generalized to include membranes of Env-presenting cells. Flow cytometry was used to analyze HEK293T cells transiently transfected with increasing amounts of DNA encoding JRFL Env, loaded with calcein dye, and treated with serial dilutions of microvirin (Q831K/M83R)-DAVEI. Comparing calcein retention against intact Env expression (via Ab 35O22) on individual cells revealed effects proportional to Env expression. "Low-Env" cells experienced transient poration and calcein leakage, while "high-Env" cells were killed. The cell-killing effect was confirmed with an independent mitochondrial activity-based cell viability assay, showing dose-dependent cytotoxicity in response to DAVEI treatment. Transfection with increasing quantities of Env DNA showed further shifts toward "High-Env" expression and cytotoxicity, further reinforcing the Env dependence of the observed effect. Controls with unlinked DAVEI components showed no effect on calcein leakage or cell viability, confirming a requirement for covalently linked DAVEI compounds to achieve Env transformation. These data demonstrate that the metastability of Env is an intrinsic property of the transmembrane protein complex and can be perturbed to cause membrane disruption in both virus and cell contexts.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Amino Acid Sequence
  • Bacterial Proteins / pharmacology*
  • Cell Membrane / drug effects
  • Cell Membrane / metabolism*
  • Cell Membrane / virology*
  • HEK293 Cells
  • HIV Fusion Inhibitors / pharmacology*
  • Humans
  • Mannose-Binding Lectin / pharmacology*
  • Protein Stability / drug effects
  • Protein Structure, Secondary
  • Virus Internalization / drug effects*
  • env Gene Products, Human Immunodeficiency Virus / antagonists & inhibitors
  • env Gene Products, Human Immunodeficiency Virus / chemistry
  • env Gene Products, Human Immunodeficiency Virus / metabolism*

Substances

  • Bacterial Proteins
  • HIV Fusion Inhibitors
  • Mannose-Binding Lectin
  • env Gene Products, Human Immunodeficiency Virus
  • microvirin protein, Microcystis aeruginosa